Filter
1670
Filtered Results: 1670
Text search:
regimens
Featured
Recommendations
189
New Publications
409
Language
Document type
No document type
1037
Guidelines
256
Studies & Reports
216
Manuals
51
Strategic & Response Plan
36
Fact sheets
36
Infographics
14
Training Material
13
Situation Updates
8
Resource Platforms
2
Online Courses
1
Countries / Regions
India
86
South Africa
54
Global
54
Kenya
40
Tanzania
40
Ethiopia
32
Western and Central Europe
32
Africa
27
Zambia
26
Uganda
25
Malawi
25
Eastern Europe
25
Latin America and the Carribbean
24
Nepal
23
Nigeria
20
Rwanda
18
Philippines
16
Bangladesh
16
Namibia
15
Ukraine
15
South–East Asia Region
14
Asia
14
Liberia
13
Ghana
13
Zimbabwe
13
Cambodia
13
Myanmar / Burma
13
Mozambique
11
Lesotho
9
Sierra Leone
8
Colombia
8
Botswana
8
Russia
8
Senegal
6
East and Southern Africa
6
West and Central Africa
6
Cameroon
5
Haiti
5
Syria
5
Thailand
5
Indonesia
5
Eswatini/ Swaziland
5
Western Pacific Region
5
Venezuela
5
Georgia
5
Congo, Democratic Republic of
4
Pakistan
4
Germany
4
Argentina
4
Albania
4
USA
3
Somalia
3
Middle East and North Africa
3
Tajikistan
3
Estonia
3
Jamaica
3
Guinea
2
South Sudan
2
Jordan
2
Afghanistan
2
Peru
2
Brazil
2
Bolivia
2
Sri Lanka
2
Eastern Europe and Central Asia
2
Paraguay
2
Bhutan
2
Timor Leste/ East Timor
2
Romania
2
Vietnam
2
Burkina Faso
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Iraq
1
Lebanon
1
Egypt
1
Gambia
1
China
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
North Macedonia
1
Greece
1
Chile
1
Other region
1
North Korea
1
Laos
1
Moldova
1
Iran
1
North America
1
Denmark
1
Tunisia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
538
Clinical Guidelines
274
Public Health
80
Women & Child Health
74
Capacity Building
31
Pharmacy & Technologies
14
Key Resources
9
Toolboxes
HIV
347
TB
319
NTDs
69
AMR
60
COVID-19
53
NCDs
45
Pharmacy
44
Mental Health
29
Refugee
22
Ebola
21
Caregiver
20
Conflict
14
Rapid Response
13
Polio
12
Disability
9
Natural Hazards
6
Planetary Health
6
Cholera
5
Global Health Education
4
Health Financing Toolbox
3
Specific Hazards
2
Social Ethics
2
Report for the WHO Meningitis Guideline Revision (May 2014)
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
July 2019
Policy brief
HIV Treatment
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection
HIV Treatment
Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This community study was designed to compare the safety and efficacy of MDA with IDA (ivermectin, diethylcarbamaz...
The Panel recommendations on initial combination regimens for the antiretroviral therapy (ART)-naive, HIV-infected patients.
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to ...
Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines. Supplement to the 2016 consolidated guidelines on the use of antire...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral ...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of...
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this ...
The 7th edition of the Orange Guide provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regimens
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of ...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred ... based on a patient’s HCV genotype and clinical history, and assess the appropriateness of continued use of certain medicines. This document also includes existing recommendations on screening for HCV infection and care of persons infected with HCV that were first issued in 2014
